Identifying Type 2 Diabetes Biomarkers That Predict Alzheimer's Disease
Author Information
Author(s): Brendan K. Ball, Hyun Park Jee, Elizabeth A. Proctor, Douglas K. Brubaker
Primary Institution: Weldon School of Biomedical Engineering, Purdue University
Hypothesis
Gene transcripts in T2D blood may predict and inform AD pathology.
Conclusion
The study identified blood-based biomarkers from T2D that can predict the onset of Alzheimer's disease.
Supporting Evidence
- Type 2 diabetes significantly elevates the risk for Alzheimer's disease by more than 60%.
- Using a computational model, the study identified genes predictive of Alzheimer's disease from T2D data.
- Therapeutic candidates were identified that may impact Alzheimer's disease development.
Takeaway
This study found that certain genes in the blood of people with type 2 diabetes can help predict if they will develop Alzheimer's disease.
Methodology
The study used a computational framework called Translatable Components Regression to analyze transcriptomic data from T2D and AD patients.
Potential Biases
Potential biases due to limited demographic representation across sex, age, and other variables.
Limitations
Data from large-scale human studies simultaneously studying the relationship between T2D and AD are still rare, limiting sample sizes and demographic representation.
Participant Demographics
The study included participants with type 2 diabetes and Alzheimer's disease, with a mean age of around 64-83 years.
Statistical Information
P-Value
p < 2.2×10−16
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website